TREATMENT OUTCOMES OF URETERAL STONES IN ELDERLY PATIENTS USING URETEROSCOPIC LITHOTRIPSYAT THONG NHAT HOSPITAL, HO CHI MINH CITY
Article Information
Download Article
How to Cite
Abstract
Evaluation of the treatment outcomes of ureteral stones in super-elderly patients using retrograde ureteroscopic lithotripsy (URSL) at Thong Nhat Hospital, Ho Chi Minh City. A retrospective descriptive study was conducted on 68 patients aged 80 years and older who underwent URSL from January 2022 to January 2025. Data on patient characteristics, stone size and location, stone-free rates, operative time, hospital stay, complications, and factors affecting treatment outcomes were collected and analyzed. The mean age of patients was 83.7 ± 3.1 years, with 57.3% being male. The average stone size was 12.3 ± 3.8 mm; 36.8% of patients had stones larger than 1.5 cm, and 30.9% had stones located in the upper third of the ureter. The stone-free rate after the first ureteroscopic lithotripsy was 84.7%, which increased to 93.8% after the second session. However, 7.4% of patients still had residual stones, mainly due to difficult anatomical locations or ureteral edema. The mean operative time was 29.4 ± 9.7 minutes (range 19–48 minutes). Complications occurred in 12.1% of cases, most commonly urinary tract infection (5.8%), mild bleeding (2.9%), and minor ureteral injury (3.4%). The mean hospital stay was 7.2 ± 1.9 days. Retrograde ureteroscopic lithotripsy represents an effective and safe treatment modality in the super-elderly population, demonstrating high stone-free rates with an acceptable complication profile. However, individualized treatment planning is essential, particularly in cases involving large calculi, proximal ureteral stones, or significant underlying comorbidities.
Keywords
References
- Tổng cục Thống kê Việt Nam, Quỹ Dân số Liên Hợp Quốc (UNFPA). Già hóa dân số và người cao tuổi ở Việt Nam: Phân tích từ Tổng điều tra Dân số 2019. Hà Nội: Nhà xuất bản Thống kê; 2021
- Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, Wein AJ, editors. Campbell-Walsh-Wein Urology. 12th ed. Philadelphia: Elsevier; 2020. Chapter 93: Strategies for Nonmedical Management of Upper Urinary Tract Calculi; p. 1180–1200
- Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, Wein AJ, editors. Campbell-Walsh-Wein Urology. 12th ed. Philadelphia: Elsevier; 2020. Chapter 94: Surgical Management of Upper Urinary Tract Calculi. p. 1201–1225.
- Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, Wein AJ, editors. Campbell-Walsh-Wein Urology. 12th ed. Philadelphia: Elsevier; 2020. Chapter 95: Lower Urinary Tract Calculi. p. 1226–1240.
- Cui Y, Cao W, Shen H, Liu J, Wei Q. Treatment outcomes of ureteroscopic lithotripsy versus extracorporeal shock wave lithotripsy for proximal ureteral stones: a meta-analysis. Urology. 2015;85(4):748–754. doi:10.1016/j.urology.2014.12.041.
- Xu L, Peng Y, Zhong W, Yu J, Zheng Y. Comparison of extracorporeal shock wave lithotripsy and ureteroscopic holmium laser lithotripsy in the treatment of ureteral stones: a meta-analysis. Medicina (Kaunas). 2021;57(12):1317. doi:10.3390/medicina57121317.
- Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 3: Ureteral Calculi. AUA Guideline for the Management of Ureteral Calculi. J Urol. 2007;178(6):2418–2434. doi:10.1016/j.juro.2007.09.107
- Kumar A, Yadav S, Srivastava A. Ureteroscopic lithotripsy: retrospective review of mid and lower ureteric stones. Urol Nephrol Open Access J. 2016;3(6):189–193. doi:10.15406/unoaj.2016.03.00106
- Inoue T, Taguchi M, Matsuzaki T, et al. Survey on ureteroscopic complications in elderly patients in Japan. Int J Urol. 2024;31(7):801–802. doi:10.1111/iju.15489
- Lee SH, Kim TH, Kang SH. Predictive factors affecting success rates of ureteroscopic lithotripsy. Investig Clin Urol. 2020;61(1):63–69.
- Chung HS, Jung HD, Kim MD. Risk factors for ureteroscopic lithotripsy failure: a multicenter study. Korean J Urol. 2020;61(2):117–122.
License
© 2025 The Author(s). Published by Journal of Health and Aging.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.